Sharon J. Bracken is President & VP at ABBOTT LABORATORIES (ABT). They have made 9 open-market trades across 1 company since 2017, most recently 2019-03-31.
CIK 0001710778
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABT | 5,936 | $686K |
Shares reported on the most recent Form 4, priced at the 2019-04-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABT | SELL | 2019-03-06 | 2019-03-08 | $77.83 | $420K | +3.9% | +2.1% | +4.1% |
| ABT | SELL | 2019-03-01 | 2019-03-04 | $78.00 | $95K | +0.5% | +1.2% | -3.6% |
| ABT | SELL | 2018-09-28 | 2018-10-02 | $73.35 | $239K | -6.1% | -5.0% | -2.0% |
| ABT | SELL | 2018-07-30 | 2018-07-31 | $65.16 | $40K | -2.0% | +2.6% | +3.0% |
| ABT | SELL · 10b5-1 | 2018-07-23 | 2018-07-24 | $63.20 | $16K | +1.7% | +2.6% | +6.8% |
| ABT | SELL | 2018-05-04 | 2018-05-08 | $58.56 | $126K | +4.9% | +7.4% | +10.9% |
| ABT | SELL | 2018-03-05 | 2018-03-07 | $60.27 | $127K | +1.4% | -6.2% | +2.7% |
| ABT | SELL | 2018-03-01 | 2018-03-02 | $58.93 | $124K | +6.7% | -1.2% | +4.4% |
| ABT | SELL | 2017-11-30 | 2017-12-01 | $56.12 | $212K | -1.9% | +4.7% | +4.7% |
| ABT | SELL | 2017-08-01 | 2017-08-03 | $49.16 | $98K | -0.9% | +3.6% | +9.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.